Impact Of Osmolality During The AAV Manufacturing Workflow | Advanced instruments
We are open and continue to provide essential lab supplies during the COVID-19 pandemic. Answers to your FAQ’s can be found here. Read More

Impact Of Osmolality During The AAV Manufacturing Workflow

Dr Adrien Soula of the Cell and Gene Therapy Catapult will present brand new data from a study, completed in June 2021, that showed a significant increase in yield and quality of an AAV resulting from a timed osmolality shift. Additionally, his data will show how the shift had a profound effect on the relative extracellular vs intracellular vector yield with exciting implications.